Our HCP antibodies are developed to produce an assay that is broadly reactive to the greatest number of HCPs possible. A broadly reactive or "generic" assay is useful for detecting HCPs in process development and quality control. It may be advisable to later develop process specific antibodies. Cygnus has much experience in development of custom process specific antibodies. The suffix indicates the type of antibody: